Literature DB >> 80688

Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin.

J J Bernier, C Florent, C Desmazures, C Aymes, C L'Hirondel.   

Abstract

Alpha1-antitrypsin was assessed, in 10 patients with protein-losing enteropathy and 13 control subjects, as an endogenous marker of plasma-protein loss into the gastrointestinal tract. Both faecal alpha1-A.T. concentrations and faecal alpha1-A.T. clearance were significantly higher in patients than in controls. Wtih clearance there was no overlap between the groups. Over 10 days the normal gastrointestinal clearance of alpha1-A.T. was 3.07 +/- 2.25 (S.D.) ml/day. Measurement of alpha1-A.T. clearance is easy and requires no radioisotopes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80688     DOI: 10.1016/s0140-6736(78)92650-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

1.  Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.

Authors:  F Boege; W Fischbach
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

2.  Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children.

Authors:  Michael B Arndt; Barbra A Richardson; Tahmeed Ahmed; Mustafa Mahfuz; Rashidul Haque; Grace C John-Stewart; Donna M Denno; William A Petri; Margaret Kosek; Judd L Walson
Journal:  Am J Trop Med Hyg       Date:  2016-06-27       Impact factor: 2.345

Review 3.  Non-invasive investigation of inflammatory bowel disease.

Authors:  J A Tibble; I Bjarnason
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Early Impact of Fontan Operation on Enteric Protein Loss.

Authors:  Jyoti K Patel; Kathleen M Loomes; David J Goldberg; Laura Mercer-Rosa; Kathryn Dodds; Jack Rychik
Journal:  Ann Thorac Surg       Date:  2015-12-01       Impact factor: 4.330

5.  Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.

Authors:  D Rigaud; J Cosnes; Y Le Quintrec; E René; J P Gendre; M Mignon
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

6.  Investigation of auranofin-induced diarrhoea.

Authors:  R Behrens; M Devereaux; B Hazleman; K Szaz; J Calvin; G Neale
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

Review 7.  Laboratory assessment of inflammatory bowel disease.

Authors:  I T Beck
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

8.  Faecal excretion of alpha-1-antitrypsin in acute diarrhoea.

Authors:  M Mäki; A Harmoinen; T Vesikari; J K Visakorpi
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

9.  Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.

Authors:  U Karbach; K Ewe; H Bodenstein
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

10.  [Chronic diarrhea in a 43-year-old patient].

Authors:  J Strehl; M Schepke; E Wardelmann; W H Caselmann; T Sauerbruch
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.